Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study

BMJ Open 2021 July 5 [Link] Aditi Bhatt, Pascal Rousset, Dario Baratti, Daniele Biacchi, Nazim Benzerdjeb, Ignace H J T de Hingh, Marcello Deraco, Vadim Gushchin, Praveen Kammar, Daniel Labow, Edward Levine, Brendan Moran, Faheez Mohamed, David Morris, Sanket Mehta, Aviram Nissan, Mohammad Alyami, Mohammad Adileh, Shoma Barat, Almog Ben Yacov, Kurtis Campbell, Kathleen Cummins-Perry,…

Read More

Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy

Techniques in Coloproctology 2020 October [Link] A Arjona-Sánchez, D Cortés-Guiral, M Duran-Martínez, P Villarejo-Campos, J M Sánchez-Hidalgo, A Casado-Adam, L Rodriguez-Ortiz, A Romero-Ruiz, B Rufian-Andujar, E Espinosa-Redondo, F Valenzuela-Molina, S Rufián-Peña, J Briceño-Delgado Abstract Background: The aim of our study was to present the technique for, and early results of complete laparoscopic pelvic peritonectomy (LPP)…

Read More

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BJS Open 2021 March 5 [Link] A Zahid, L Clarke, N Carr, K Chandrakumaran, A Tzivanakis, S Dayal, F Mohamed, T Cecil, B J Moran Abstract Background: Multicystic peritoneal mesothelioma (MCPM) is a rare neoplasm, generally considered a borderline malignancy, best treated by cytoreductive surgery (CRS) to remove macroscopic disease, combined with hyperthermic intraperitoneal chemotherapy…

Read More

Multicystic peritoneal mesothelioma treated with complete cytoreductive surgery, peritonectomy and hyperthermic intra-peritoneal chemotherapy-A case report

International Journal of Surgery Case Reports 2020 [Link] Naveen Padmanabhan, Haruaki Ishibashi, Kazurou Nishihara, Shouzou Sako, Kanji Katayama, Satoshi Wakama, Yasuyuki Kamada, Yutaka Yonemura Abstract Background: Multicystic Peritoneal mesothelioma is a rare and distinct variety of peritoneal mesothelioma with borderline malignant potential. Conventional Tumor bulking has been associated with recurrence of 45-50 %. Hence a…

Read More

A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis.

Surgical Endoscopy 2018 July 12 [Link] Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D, Rufian-Peña S, Morales R, van der Speet Abstract BACKGROUND: Minimally invasive surgery is playing an increasing role in the treatment of patients with gastrointestinal and gynaecological malignancies as the data show reduced morbidity, faster recovery and similar…

Read More

Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma

Journal of Thoracic Disease 2016 August 8 [Link] Sandri A, Guerrera F, Roffinella M, Olivetti S, Costardi L, Oliaro A, Filosso PL, Lausi PO, Ruffini E Abstract BACKGROUND: To assess the trend of our surgical patients affected by malignant pleural mesothelioma (MPM) and submitted to diagnostic/palliative or curative surgical procedures and to validate the European Organisation for Research…

Read More

Indication of Peritonectomy for Peritoneal Dissemination

Gan To Kagaku Ryoho. 2010 Nov;37(12):2306-2311. [Link] Yonemura Y, Tsukiyama G, Miyata R, Sako S, Endou Y, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Hagiwara A, Li Y. NPO Organization to Support Peritoneal Dissemination Treatment. Abstract A total of 521 patients with peritoneal carcinomatosis (PC) were treated by peritonectomy and…

Read More

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience

Journal of Surgical Oncology. 2009 Feb 1;99(2):109-13. [Link] Chua TC, Yan TD, Morris DL. Department of Surgery, University of New South Wales, St George Hospital, Kogarah, Sydney, NSW, Australia. Abstract Aims: Peritoneal mesothelioma is a rapidly progressing malignancy with a median survival of 6-12 months. Palliative surgery, chemotherapy and radiotherapy are futile and have not…

Read More